Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 11/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16007865 | 0.89 | LMNA (0.35) | LMNAOPRK1OPRM1OPRD1KDM4E | |
| SCHEMBL16007750 | 0.88 | LMNA (0.34) | LMNAOPRK1OPRM1OPRD1KDM4E | |
| SCHEMBL16007804 | 0.86 | LMNA (0.34) | LMNAOPRK1OPRM1OPRD1KDM4E | |
| SCHEMBL16007717 | 0.84 | LMNA (0.36) | LMNAOPRK1OPRM1OPRD1KDM4E | |
| SCHEMBL16007805 | 0.82 | EPHX2 (0.33) | LMNAOPRK1MEN1NPC1RAB9A | |
| SCHEMBL114934 | 0.78 | — | — | |
| SCHEMBL16007758 | 0.77 | LMNA (0.34) | LMNAOPRK1OPRM1OPRD1MEN1 | |
| SCHEMBL14848362 | 0.77 | OPRK1 (0.35) | LMNAOPRK1MEN1NPC1RAB9A | |
| SCHEMBL28420945 | 0.75 | OPRK1 (0.33) | LMNAOPRK1MEN1NPC1RAB9A | |
| SCHEMBL16007797 | 0.75 | LMNA (0.33) | LMNAOPRK1OPRM1OPRD1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8975350-B2 | Polymerizable composition, resin moldings and manufacturing process therefor, and laminates | ZEON CORPORATION (JP) | 2015-03-10 | — | — | US | disclosed |
| US-20140256878-A1 | POLYMERIZABLE COMPOSITION, RESIN MOLDINGS AND MANUFACTURING PROCESS THEREFOR, AND LAMINATES | ZEON CORPORATION (JP) | 2014-09-11 | — | — | US | disclosed |
| US-8742155-B2 | Preparation of organoxysilyl or siloxy-containing ethylnorbornene compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-06-03 | — | — | US | disclosed |
| CN-103717671-A | Polymerizable composition, resin moldings and manufacturing process therefor, and laminates | ZEON CORP | 2014-04-09 | — | — | CN | disclosed |
| US-20130066095-A1 | PREPARATION OF ORGANOXYSILYL OR SILOXY-CONTAINING ETHYLNORBORNENE COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130066095-A1 | PREPARATION OF ORGANOXYSILYL OR SILOXY-CONTAINING ETHYLNORBORNENE COMPOUND | SIK2, RNF168, OR51E2 | LMNA 3617/4885OPRK1 1891/4885OPRM1 1678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.